Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Clonal Cytopenia of Undetermined Significance × enasidenib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 9 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Neoplasms 1 Myeloproliferative Disorders 1 Lymphoma, T-Cell 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Clonal Cytopenia of Undetermined Significance 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

enasidenib 1 canakinumab 1 X-Rays 1 Specimen Handling 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05102370 2026-01-27

A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Memorial Sloan Kettering Cancer Center

Phase 1 Completed

Classical hematology

Clonal Cytopenia of Undetermined Significance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡